Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$108.08 USD
-0.62 (-0.57%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $108.07 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ZBH 108.08 -0.62(-0.57%)
Will ZBH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZBH
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zimmer Biomet (ZBH) Beats on Q2 Earnings, Cuts Revenue View
Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Zimmer Biomet (ZBH) Tops Q2 Earnings and Revenue Estimates
Other News for ZBH
Buy Rating Reaffirmed for Zimmer Biomet Holdings Amid Strong Financial Performance and Growth Prospects
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insight
Zimmer Biomet price target lowered by $10 at Raymond James, here's why
Analysts Conflicted on These Healthcare Names: Revolution Medicines (RVMD), Personalis (PSNL) and Zimmer Biomet Holdings (ZBH)
Truist Financial Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)